Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator historically used for peripheral vascular diseases. Its efficacy is not well-established for many of its former indications.
## Primary Indications
* Intermittent claudication.
* Vascular spasms.
* Raynaud's disease.
## Adult Dosing
* **Intermittent claudication/Vascular spasms:** 10-20 mg orally every 3-4 times daily.
* Maximum dose: 40 mg daily. Doses exceeding this are generally not recommended due to lack of proven benefit and increased risk of adverse effects.
## Pediatric Dosing
No established pediatric dosing. Use is generally not recommended in children.
## Dose Adjustments
* **Renal Impairment:** Use with caution. No specific dose adjustments are established, but reduced frequency may be considered based on clinical response and renal function.
* **Hepatic Impairment:** Use with caution. No specific dose adjustments are established.
## Contraindications
* Hypersensitivity to isoxsuprine.
* Should not be administered immediately postpartum or in patients with a bleeding tendency.
## Adverse Effects
* **Common:** Flushing, hypotension, dizziness, nausea, vomiting, abdominal distress, rash, weakness, palpitations, tachycardia.
* **Less Common:** Gastrointestinal bleeding.
## Key Drug Interactions
* **Antihypertensives:** May potentiate hypotensive effects. Monitor blood pressure closely.
* **Anticoagulants (e.g., warfarin):** Increased risk of bleeding. Use with caution and monitor coagulation parameters.
## Monitoring
* Blood pressure and heart rate.
* Signs and symptoms of peripheral vascular disease improvement.
* Signs of bleeding.
## Clinical Pearls
* The effectiveness of isoxsuprine is controversial, and it is not a first-line therapy for most peripheral vascular diseases.
* Administer oral doses with food to minimize gastrointestinal upset.
* Doses should be titrated gradually to assess tolerance and efficacy.
***
**Disclaimer:** This information is intended for clinical professionals. Always consult the most current prescribing information and institutional protocols before making any clinical decisions.
